Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Other OTC
  5. CytoDyn Inc.
  6. News
  7. Summary
    CYDY   US23283M1018

CYTODYN INC.

(CYDY)
Delayed Other OTC  -  03:59 2021-04-01 pm EDT
3.190 USD   +18.15%
09/19CytoDyn to Hold Webcast to Provide a Quarterly Company Update
GL
08/31CYTODYN : OTCQB Certification
PU
08/31CYTODYN INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
SummaryChartsNewsRatingsCalendarCompanyFunds 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about CYTODYN INC.
09/19CytoDyn to Hold Webcast to Provide a Quarterly Company Update
GL
08/31CYTODYN : OTCQB Certification
PU
08/31TRANSCRIPT : CytoDyn Inc. - Shareholder/Analyst Call
CI
08/30CytoDyn Inc. Approves the Appointment of Ryan Dunlap as Director
CI
08/15CytoDyn Inc. Reports Earnings Results for the Full Year Ended May 31, 2022
CI
08/15CytoDyn Inc. Auditor Raises 'Going Concern' Doubt
CI
07/25CYTODYN : Unregistered Sales of Equity Securities - Form 8-K/A
PU
07/25CYTODYN : Material Definitive Agreement - Form 8-K
PU
07/13CytoDyn Appoints Cyrus Arman, Ph.D., MBA, as President
GL
07/13CytoDyn Appoints Cyrus Arman, Ph.D., MBA, as President
GL
07/13CytoDyn Inc. Appoints Cyrus Arman as President
CI
07/11CytoDyn Highlights NIH Grant for HIV Functional Cure Preclinical Study of Gene Therapy ..
GL
07/11CytoDyn Highlights NIH Grant for HIV Functional Cure Preclinical Study of Gene Therapy ..
AQ
07/11CytoDyn Inc. Announces Preclinical Study in Nonhuman Primates That Will Evaluate the Po..
CI
06/30CYTODYN : Unregistered Sales of Equity Securities - Form 8-K
PU
More most relevant news
All news about CYTODYN INC.
09/19CytoDyn to Hold Webcast to Provide a Quarterly Company Update
GL
08/31CYTODYN : OTCQB Certification
PU
08/31CYTODYN INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission..
AQ
08/31TRANSCRIPT : CytoDyn Inc. - Shareholder/Analyst Call
CI
08/30CYTODYN INC. : Change in Directors or Principal Officers (form 8-K)
AQ
08/30CytoDyn Inc. Approves the Appointment of Ryan Dunlap as Director
CI
08/15CYTODYN INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS O..
AQ
08/15CytoDyn Inc. Reports Earnings Results for the Full Year Ended May 31, 2022
CI
08/15CytoDyn Inc. Auditor Raises 'Going Concern' Doubt
CI
08/05CYTODYN INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
AQ
More news
News in other languages on CYTODYN INC.
08/30CytoDyn Inc. approuve la nomination de Ryan Dunlap en tant que directeur
08/15CytoDyn Inc. annonce ses résultats pour l'année complète se terminant le 31 mai 2022
08/15CytoDyn Inc. Le vérificateur remet en question la continuité de l'exploitation.
07/13CytoDyn Inc. nomme Cyrus Arman au poste de président
07/11CytoDyn Inc. annonce une étude préclinique sur des primates non humains qui évaluera l'..
05/23CytoDyn Inc. annonce la démission de Jordan G. Naydenov en tant que membre du conseil d..
04/25CytoDyn Inc. annonce des changements de direction
04/11CytoDyn Inc. annonce ses résultats pour le troisième trimestre et les neuf mois terminé..
03/30CytoDyn Inc. annonce la nomination de Karen J. Brunke, Ph.D., au poste de directeur de ..
03/30CytoDyn annonce un arrêt clinique partiel du programme VIH et un arrêt clinique complet..
More news
Press releases
09/19CytoDyn to Hold Webcast to Provide a Quarterly Company Update
GL
08/31CYTODYN : OTCQB Certification
PU
08/31CYTODYN INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission..
AQ
08/30CYTODYN INC. : Change in Directors or Principal Officers (form 8-K)
AQ
08/15CYTODYN INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS O..
AQ
More press releases
Upcoming event on CYTODYN INC.